Skip to main content

Sorrell v. IMS Health Inc.

Docket No.10-779
Op. Below2d Cir.
ArgumentApr 26, 2011

Holding

Vermont's Prescription Confidentiality Law, which absent the prescriber's consent prohibits the sale of prescriber-identifying information, as well as the disclosure or use of that information for marketing purposes, is subject to heightened judicial scrutiny because it imposes content- and speaker-based burdens on protected expression. Vermont's justifications for the prohibition cannot withstand such heightened scrutiny.

Judgment

Affirmed, 6-3, in an opinion by Anthony McLeod Kennedy on Jun 23, 2011. Justice Breyer filed a dissenting opinion, which was joined by Justices Ginsburg and Kagan.

Merits Briefs

Amicus Briefs

[##CERT-STAGE##]

Welcome to SCOTUSblog

Tell us a bit about yourself so we can tailor what you see. You can update these any time in your account.